GPRC5A and urinary bladder cancer: These studies support the rationality for the overexpression of EV SLC2A1, GPRC5A and KRT17 in bladder cancer urine, however further study is necessary to determine if these EV mRNA are originated from tumors or associated with the overexpression of corresponding proteins in tumors.